Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

EVEXITHROID 90 MG TABLET

LEVOTHYROXINE and LIOTHYRONINE
$1.0509per EA

Strength

57; 13.5 ug/1; ug/1

Manufacturer

Trifluent Pharma LLC

NDC

73352069810

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LEVOTHYROXINE; LIOTHYRONINE

Approval Type

Unapproved

On Market Since

10/12/2025

Pharmacological Classes

Thyroxine
Triiodothyronine
l-Thyroxine
l-Triiodothyronine

Price History

1W

0.0%

1M

+0.1%

3M

-0.6%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

LEVOTHYROXINE 25 MCG TABLET
Generic
00378180010•Mylan Pharmaceuticals Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00378180077•Mylan Pharmaceuticals Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00480868210•Teva Pharmaceuticals USA Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00480868298•Teva Pharmaceuticals USA Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00527328043•Lannett Company Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00527328046•Lannett Company Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00904694961•Major Pharmaceuticals
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
16729044715•Accord Healthcare Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
16729044717•Accord Healthcare Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
31722028410•Camber Pharmaceuticals Inc.
$0.0380
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy